Curaleaf issues statement on reported interest in Cronos

Curaleaf Holdings Inc.
CURA,
+15.80%
responded late Friday to reports it was among those interested in buying Canadian cannabis company Cronos Inc.
CRON,
+6.91%.
Curaleaf said the Canadian Investment Regulatory Organization had requested a comment on market speculation. “As previously disclosed, the company regularly examines transactions including partnerships, possible acquisitions, sales and mergers with third parties,” the company said in a statement. “There is no guarantee that any potential transaction will materialize.” Earlier Friday, Curaleaf said it did not comment on market speculation about reports of a transaction unless required by law. Shares of Curaleaf closed Friday up nearly 16%, while Cronos shares finished up nearly 7%.